What Is GLP-1? How GLP-1 Medications Work for Weight Loss

Medically reviewed content. Written by Joe Miller, BS Kinesiology & Exercise Science, A4M Fellowship, NASM & NSCA CSCS Certified. Last updated March 2026.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription and medical supervision. Individual results vary. Consult your physician before starting any weight loss medication.

GLP-1 has become one of the most talked-about topics in modern medicine, yet many people still wonder what it actually is and how it works. Whether you have heard the term from your doctor, read about it in the news, or seen it mentioned alongside medications like Wegovy and Ozempic, understanding GLP-1 starts with the hormone itself.

GLP-1, short for glucagon-like peptide-1, is a naturally occurring hormone your body produces every time you eat. It plays a central role in regulating blood sugar, controlling appetite, and signaling fullness to your brain. GLP-1 medications build on this natural system to deliver powerful metabolic benefits, including clinically significant weight loss of 15 to 22 percent of body weight in major clinical trials.

Ready to explore whether GLP-1 therapy is right for you? Learn about 1st Optimal’s physician-supervised GLP-1 weight loss program and start with a comprehensive lab evaluation.

What Is GLP-1 and Why Does It Matter?

GLP-1 stands for glucagon-like peptide-1. It is a hormone produced by specialized L-cells in the lining of your small intestine. When you eat a meal, particularly one containing carbohydrates, proteins, and fats, these cells release GLP-1 into your bloodstream within minutes.

The hormone earned its name because its molecular structure resembles glucagon, another hormone involved in blood sugar regulation. However, GLP-1 does the opposite of glucagon in many ways. While glucagon raises blood sugar by telling your liver to release stored glucose, GLP-1 helps lower blood sugar by stimulating insulin release from the pancreas.

GLP-1 belongs to a family of hormones called incretins. These gut-derived hormones are responsible for what scientists call the “incretin effect,” which accounts for roughly 50 to 70 percent of the insulin response after a meal. This discovery revealed that the gut plays a far larger role in metabolic regulation than previously understood, and it set the stage for the development of GLP-1 medications.

How Does GLP-1 Work in Your Body?

Natural GLP-1 performs several critical functions simultaneously. Understanding these mechanisms explains why GLP-1 medications have become such effective tools for both blood sugar management and weight loss.

Insulin release and blood sugar regulation: GLP-1 binds to receptors on the beta cells of your pancreas, triggering insulin release in a glucose-dependent manner. This means insulin is released only when blood sugar is elevated, which reduces the risk of dangerously low blood sugar (hypoglycemia) compared to older diabetes medications.

Glucagon suppression: At the same time, GLP-1 suppresses the release of glucagon from the alpha cells of the pancreas. Since glucagon tells the liver to release stored sugar, this dual action helps keep blood sugar levels stable after meals.

Appetite regulation: GLP-1 receptors are found throughout the brain, particularly in the hypothalamus and brainstem, regions that control hunger and satiety. When GLP-1 activates these receptors, it reduces appetite, decreases food cravings, and increases feelings of fullness.

Delayed gastric emptying: GLP-1 slows the rate at which food moves from your stomach into the small intestine. This keeps you feeling satisfied longer after eating and prevents the rapid blood sugar spikes that can follow a meal.

Here is the challenge: your body breaks down natural GLP-1 extremely quickly. An enzyme called DPP-4 (dipeptidyl peptidase-4) degrades GLP-1 within approximately two minutes of its release. Only about 10 to 15 percent of the GLP-1 you produce actually reaches your bloodstream in active form. This rapid degradation is exactly why GLP-1 medications were developed. They are engineered to resist DPP-4 breakdown, allowing them to remain active for hours or even days.

What Are GLP-1 Medications?

GLP-1 medications, also called GLP-1 receptor agonists, are prescription drugs that mimic the action of natural GLP-1 but are chemically modified to last much longer in the body. While your natural GLP-1 is destroyed within minutes, these medications can remain active for up to a week depending on the specific drug.

The science behind GLP-1 drugs has a fascinating origin. Researchers discovered that the Gila monster, a venomous lizard native to the southwestern United States, produces a compound called exendin-4 in its saliva. This compound binds to GLP-1 receptors and resists DPP-4 degradation, which led to the development of the first GLP-1 receptor agonist, exenatide (Byetta), approved in 2005.

Since then, pharmaceutical companies have developed increasingly effective GLP-1 medications with longer durations of action and greater metabolic benefits. Originally approved to treat type 2 diabetes, researchers discovered that these medications also produce significant weight loss, leading to new formulations approved specifically for weight management.

GLP-1 receptor agonists work because they activate the same receptors as your natural hormone but with sustained, consistent signaling rather than the brief pulses your body produces. This sustained activation amplifies the appetite-suppressing, blood-sugar-lowering, and gastric-slowing effects far beyond what natural GLP-1 can achieve.

Considering GLP-1 therapy? At 1st Optimal, every program begins with comprehensive diagnostic testing to determine whether GLP-1 medications are appropriate for your unique metabolic profile. Book a consultation to get started.

What Types of GLP-1 Drugs Are Available?

Several GLP-1 medications are available, each with distinct characteristics. Here is how the primary options compare:

Medication	Brand Names	Mechanism	Dosing	Avg. Weight Loss
Semaglutide	Wegovy, Ozempic	GLP-1 receptor agonist	Once weekly injection	15-17%
Tirzepatide	Zepbound, Mounjaro	Dual GLP-1 and GIP agonist	Once weekly injection	20-22%
Liraglutide	Saxenda, Victoza	GLP-1 receptor agonist	Daily injection	5-8%

Semaglutide (Wegovy for weight management, Ozempic for type 2 diabetes) is the most widely studied GLP-1 receptor agonist for weight loss. The STEP clinical trial program demonstrated that participants receiving semaglutide 2.4 mg lost an average of 14.9 percent of body weight over 68 weeks, with the newer high-dose formulation (Wegovy HD at 7.2 mg) showing up to 21 percent weight loss (New England Journal of Medicine, 2021).

Tirzepatide (Zepbound for weight management, Mounjaro for type 2 diabetes) is a newer medication that acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism may explain its higher efficacy. In the SURMOUNT-1 trial, participants on the highest dose lost an average of 22.5 percent of body weight over 72 weeks (New England Journal of Medicine, 2022).

Liraglutide (Saxenda for weight management, Victoza for diabetes) is an older GLP-1 medication that requires daily injections and produces more modest weight loss of roughly 5 to 8 percent. It remains an option for patients who may not tolerate the newer medications. For a deeper comparison of semaglutide and tirzepatide, see our GLP-1 medications comparison guide.

How Do GLP-1 Medications Help With Weight Loss?

GLP-1 drugs promote weight loss through multiple complementary mechanisms that work together to create a sustained caloric deficit without the constant hunger that makes traditional dieting difficult.

Appetite suppression and satiety: By activating GLP-1 receptors in the hypothalamus and brainstem, these medications reduce hunger signals and increase feelings of fullness. Research shows patients on GLP-1 medications naturally consume 20 to 40 percent fewer calories per day without feeling deprived.

Reduced food cravings: GLP-1 receptor activation in brain reward centers decreases cravings for high-calorie, high-fat foods. Studies indicate these medications alter food reward pathways, making patients less likely to overeat or engage in emotional eating.

Sustained metabolic improvement: Beyond appetite effects, GLP-1 medications improve insulin sensitivity, stabilize blood sugar, and reduce inflammation. These metabolic improvements create an internal environment more favorable for fat loss.

The clinical evidence supporting GLP-1 weight loss is extensive. The STEP 1 trial (New England Journal of Medicine, 2021) showed semaglutide 2.4 mg produced 14.9 percent body weight loss versus 2.4 percent with placebo over 68 weeks. The SURMOUNT-1 trial (New England Journal of Medicine, 2022) demonstrated tirzepatide at the highest dose produced 22.5 percent body weight loss. Earlier SCALE trials showed liraglutide achieved approximately 8 percent weight loss, establishing the foundation for this medication class. For more detail on clinical results and expected outcomes, read our full article on GLP-1 weight loss results and expectations.

Who Should Consider GLP-1 Therapy?

GLP-1 medications are typically appropriate for adults who meet specific clinical criteria:

• BMI of 30 or higher (classified as obesity)
• BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease
• Individuals whose weight loss has plateaued despite consistent nutrition and exercise efforts
• Those with insulin resistance or metabolic dysfunction affecting their ability to lose weight

A thorough medical evaluation is essential before starting GLP-1 therapy. This should include comprehensive lab work to assess metabolic health markers, hormone levels, thyroid function, and kidney and liver health. GLP-1 medications are not recommended for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN2), a history of pancreatitis, or those who are pregnant or planning pregnancy.

The right medication, dosage, and supporting lifestyle protocol vary significantly from person to person. A data-driven approach that includes baseline diagnostic testing ensures the medication selected aligns with your specific metabolic profile and health goals.

What Are the Common Side Effects of GLP-1 Medications?

Most side effects of GLP-1 medications are gastrointestinal and tend to be most noticeable during the initial weeks of treatment or when the dose is increased. Common side effects include:

• Nausea: The most frequently reported side effect, affecting approximately 40 to 50 percent of patients initially. It typically decreases significantly within 4 to 8 weeks as the body adjusts.
• Constipation or diarrhea: Changes in bowel habits occur in roughly 20 to 30 percent of patients and are usually manageable with adequate hydration and fiber intake.
• Reduced appetite: While this is a primary therapeutic effect, some patients experience appetite reduction beyond what feels comfortable, particularly at higher doses.
• Injection site reactions: Mild redness or irritation at the injection site affects a small percentage of patients.

The standard approach to minimizing side effects is gradual dose titration. Most prescribers start at the lowest available dose and increase every 4 weeks based on tolerability. This slow escalation allows your body to adapt and significantly reduces the severity of gastrointestinal symptoms.

More serious but rare side effects include pancreatitis, gallbladder problems, and changes in kidney function. These underscore why medical supervision throughout GLP-1 therapy is critical. Regular monitoring through follow-up lab work helps detect any concerns early. For a comprehensive guide to GLP-1 receptor agonists and their safety profiles, visit our GLP-1 receptor agonists guide.

How 1st Optimal Approaches GLP-1 Therapy

At 1st Optimal, GLP-1 therapy is part of a comprehensive, physician-supervised medical weight loss program designed for lasting results. Rather than simply prescribing a medication, we take a data-driven approach that addresses the full picture of your metabolic health.

Comprehensive diagnostic testing: Every program begins with in-depth lab work, including a complete metabolic panel, fasting insulin, hemoglobin A1c, lipid panel, thyroid panel, and hormone evaluation. This data guides medication selection and dosing, ensuring the protocol is personalized to your biology.

Personalized medication selection: Based on your lab results, health history, and goals, your provider determines whether semaglutide, tirzepatide, or compounded semaglutide is the best fit. Compounded formulations may offer cost-effective alternatives while maintaining therapeutic efficacy.

Ongoing monitoring and optimization: Your dedicated Membership Manager coordinates regular check-ins and follow-up labs to track progress, adjust dosing, and ensure the medication continues working safely. This proactive approach means adjustments are made based on data, not guesswork.

Lifestyle integration: GLP-1 medications work best when paired with strategic nutrition (particularly adequate protein intake to preserve lean muscle mass), resistance training, sleep optimization, and stress management. Your care team provides guidance on these foundational elements to maximize your results.

Take the next step toward your health goals. Explore 1st Optimal’s GLP-1 medical weight loss program and discover how a personalized, data-driven approach can help you achieve lasting results.

Frequently Asked Questions About GLP-1

What does GLP-1 stand for?

GLP-1 stands for glucagon-like peptide-1. It is a naturally occurring hormone produced by L-cells in the small intestine after you eat. It plays a key role in regulating blood sugar, insulin secretion, appetite, and gastric emptying.

Are GLP-1 medications the same as insulin?

No. GLP-1 medications and insulin are different. Insulin directly lowers blood sugar by helping cells absorb glucose. GLP-1 medications stimulate your pancreas to release insulin only when blood sugar is elevated, which means they carry a much lower risk of causing hypoglycemia (dangerously low blood sugar).

How much weight can you lose on GLP-1 medications?

Clinical trials show weight loss ranging from 5 to 22 percent of body weight depending on the medication and dose. Semaglutide (Wegovy) produces approximately 15 to 17 percent weight loss, while tirzepatide (Zepbound) has shown up to 22.5 percent. Results vary based on adherence, lifestyle factors, and individual biology.

How long do you need to take GLP-1 medications?

Research indicates that weight regain is common after discontinuing GLP-1 medications. One clinical trial showed participants who stopped tirzepatide regained approximately 14 percent of lost weight within a year. Most providers recommend long-term or ongoing use, with periodic reassessment of dosing and continued lifestyle support.

Is metformin a GLP-1 medication?

No. Metformin is a different class of medication (a biguanide) that works primarily by reducing glucose production in the liver and improving insulin sensitivity. While both metformin and GLP-1 medications can be used to manage type 2 diabetes, they work through different mechanisms. In some cases, they may be prescribed together.

Is Ozempic the same as Wegovy?

Ozempic and Wegovy both contain semaglutide, but they are approved for different purposes. Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is approved specifically for chronic weight management. Wegovy is available at a higher maximum dose (2.4 mg versus 2.0 mg for Ozempic).

What is the difference between GLP-1 and GIP?

GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are both incretin hormones that stimulate insulin release after eating. Tirzepatide (Zepbound, Mounjaro) is the first medication that targets both GLP-1 and GIP receptors simultaneously. This dual action may contribute to its higher average weight loss compared to GLP-1-only medications.

Can GLP-1 medications help with conditions other than weight loss?

Yes. Beyond weight loss, GLP-1 medications have demonstrated benefits for cardiovascular health, including reductions in blood pressure and improvements in cholesterol profiles. The SELECT trial showed semaglutide reduced major adverse cardiovascular events in adults with obesity and cardiovascular disease. Emerging research also suggests potential benefits for liver health, cognitive function, and inflammation reduction.

Do GLP-1 medications require a prescription?

Yes. All GLP-1 medications require a prescription from a licensed healthcare provider. A medical evaluation, including lab work and health history review, is necessary to determine whether you are a candidate and which medication is appropriate for you.

What should you look for in a GLP-1 provider?

Look for a provider who performs comprehensive diagnostic testing before prescribing, offers personalized medication selection based on your lab results, provides ongoing monitoring with follow-up labs, and integrates lifestyle support (nutrition, exercise, stress management) into the treatment plan. Avoid providers who prescribe without lab work or medical evaluation.